Cargando…

High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer

INTRODUCTION: A standard treatment for stage II colorectal cancer (CRC) is surgical resection without adjuvant chemotherapy. However, the recurrence rate of these patients is approximately 20%. To date, there are no robust biomarkers suitable for predicting recurrence in stage II CRC patients. In th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamazaki, Nobuyoshi, Koga, Yoshikatsu, Taniguchi, Hirokazu, Kojima, Motohiro, Kanemitsu, Yukihide, Saito, Norio, Matsumura, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351683/ https://www.ncbi.nlm.nih.gov/pubmed/28036302 http://dx.doi.org/10.18632/oncotarget.14344

Ejemplares similares

High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer
por: Shiraishi, Takuya, et al.
Publicado: (2021)

Multiple rapidly growing desmoid tumors that were difficult to distinguish from recurrence of rectal cancer
por: Nakanishi, Koki, et al.
Publicado: (2017)

Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients
por: Yasui, Kohei, et al.
Publicado: (2020)

Predictive relevance of lymphovascular invasion in T1 colorectal cancer before endoscopic treatment
por: Inoki, Kazuya, et al.
Publicado: (2017)

Metachronous metastasis to inguinal lymph nodes from sigmoid colon adenocarcinoma with abdominal wall metastasis: a case report
por: Tanabe, Taro, et al.
Publicado: (2019)

Endoscopic Resection Before Surgery Does Not Affect the Recurrence Rate in Patients With High-Risk T1 Colorectal Cancer
por: Takamaru, Hiroyuki, et al.
Publicado: (2021)

ROK study-C (Rainbow of KIBOU study-colorectum): a colorectal cancer survivor cohort study on food, nutrition, physical activity, psychosocial factors and its influences on colorectal cancer recurrence, survival and quality of life in Japan
por: Mizota, Yuri, et al.
Publicado: (2018)

A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study)
por: Moritani, Konosuke, et al.
Publicado: (2019)

miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4
por: Liu, Yanqing, et al.
Publicado: (2016)

Imaging mass spectrometry for the precise design of antibody-drug conjugates
por: Fujiwara, Yuki, et al.
Publicado: (2016)

Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models
por: Tsumura, Ryo, et al.
Publicado: (2019)

Serum patterns of mir-23a and mir-181b in irritable bowel syndrome and colorectal cancer - A pilot study
por: Chira, Alexandra, et al.
Publicado: (2020)

Let-7, Mir-98 and Mir-181 as Biomarkers for Cancer and Schizophrenia
por: Rizos, Emmanouil, et al.
Publicado: (2015)

Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer
por: Takamizawa, Yasuyuki, et al.
Publicado: (2020)

Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial
por: Sasaki, Takeshi, et al.
Publicado: (2017)

Pre-miRNA Loop Nucleotides Control the Distinct Activities of mir-181a-1 and mir-181c in Early T Cell Development
por: Liu, Gwen, et al.
Publicado: (2008)

Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines
por: Fukuoka, Shota, et al.
Publicado: (2016)

Preparation and characterization of anti-tissue factor single-chain variable fragment antibody for cancer diagnosis
por: Sato, Ryuta, et al.
Publicado: (2014)

The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution
por: Yasunaga, Masahiro, et al.
Publicado: (2013)

Correction: Let-7, Mir-98 and Mir-181 as Biomarkers for Cancer and Schizophrenia
por: Rizos, Emmanouil, et al.
Publicado: (2015)

Assessment of elasticity of colorectal cancer tissue, clinical utility, pathological and phenotypical relevance
por: Kawano, Shingo, et al.
Publicado: (2015)

miR-181 suppresses metastasis via MMP-14
por: Roth, Eric, et al.
Publicado: (2015)

Regulation of miR-181a expression in T cell aging
por: Ye, Zhongde, et al.
Publicado: (2018)

The expression and role of miR-181a in multiple myeloma
por: Yuan, Ruili, et al.
Publicado: (2018)

MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme
por: Marisetty, Anantha, et al.
Publicado: (2020)

Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in Japan
por: Shida, Dai, et al.
Publicado: (2018)

Despite high levels of expression in thymic epithelial cells, miR-181a1 and miR-181b1 are not required for thymic development
por: Stefanski, Heather E., et al.
Publicado: (2018)

Development of Antibody–Drug Conjugates Using DDS and Molecular Imaging
por: Yasunaga, Masahiro, et al.
Publicado: (2017)

Histopathological atlas of desmoplastic reaction characterization in colorectal cancer
por: Ueno, Hideki, et al.
Publicado: (2021)

Morphological Analyses of Colorectal Adenocarcinomas in Japanese Familial Adenomatous Polyposis Patients
por: Suzuki, Yozo, et al.
Publicado: (2022)

Treatment outcomes of endoscopic submucosal dissection and surgery for colorectal neoplasms in patients with ulcerative colitis
por: Kasuga, Kengo, et al.
Publicado: (2021)

Elastic Laminal Invasion in Colon Cancer: Diagnostic Utility and Histological Features
por: Kojima, Motohiro, et al.
Publicado: (2012)

miR-181a Regulates Inflammation Responses in Monocytes and Macrophages
por: Xie, Weidong, et al.
Publicado: (2013)

FAMLF is a target of miR-181b in Burkitt lymphoma
por: Li, J.G., et al.
Publicado: (2017)

The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer
por: Indrieri, Alessia, et al.
Publicado: (2020)

miR-181a-regulated pathways in T-cell differentiation and aging
por: Kim, Chulwoo, et al.
Publicado: (2021)

Role of miR-181a-5p in cancer (Review)
por: Li, Junxin, et al.
Publicado: (2023)

miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
por: Henriques, Daniel G., et al.
Publicado: (2023)

miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer
por: Guo, Xiaofeng, et al.
Publicado: (2017)

PTPN22 Silencing in Human Acute T-Cell Leukemia Cell Line (Jurkat Cell) and its Effect on the Expression of miR-181a and miR-181b
por: Baghbani, Elham, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4umggmena89jinb8a0b63o70kh